MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Cash Flow Overview

Change in Cash
-$625,419
Unit: Dollar
Positive Cash Flow Breakdown
    • Prepaid expenses and other curre...
    • Amortization of prepaid stock-ba...
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Proceeds from the sale of short-...
    • Net loss
    • Accounts payable and accrued exp...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Net loss
-832,829
1,699,051
-1,110,438
-2,235,730
Amortization expense
2,938
-5,566
2,938
5,565
Amortization of prepaid stock-based professional fees
62,500
26,712
-
-
Net realized gain on short-term debt investments
-3,054
-
0
3,911
Unrealized gain on short-term tokenized investment funds
4,961
-2,060
-
-
Staking income on crypto assets
1,147
191
-
-
Realized loss on crypto assets
-2,073
-
-
-
Unrealized loss on crypto assets, at fair value
-35,795
-50,658
-2,690
-
Impairment loss on crypto assets, at cost
0
29,911
-
-
Stock-based compensation
39,174
-8,093
47,267
17,445
Common stock issued for acquired technology expensed
0
195,775
518,225
-
Gain on settlement of accounts payable and accrued expenses
91,645
-
-
-
Prepaid expenses and other current assets
-186,016
-38,239
56,592
79,186
Accounts payable and accrued expenses
-178,917
989,920
-341,558
-593,700
Deferred revenue
-1
36,051
-18,025
-36,051
Net cash used in operating activities
-781,861
3,058,438
-955,493
-2,925,568
Proceeds from the sale of short-term debt investments
-1,113,374
-
0
1,315,653
Purchases of short-term debt investments
18,840
-57,910
20,501
56,170
Proceeds from the sale of crypto assets, at fair value
0
45,188
-
-
Purchases of crypto assets, at fair value
0
-24,983
74,973
-
Netcash provided by investing activities
183,439
-1,187,572
-95,474
1,259,483
Net proceeds from sale of common stock and pre-funded warrants
-
-
0
1,593,897
Purchase of treasury stock
-
-
-
0
Proceeds from exercise of warrants, net of offering costs
-
-
634,922
500,061
Payment of deferred offering costs
26,997
-
-
-
Net cash (used in) provided by financing activities
-2,755,877
-
634,922
2,093,958
Net(decrease) increase in cash and cash equivalents
-625,419
-858,014
-416,045
427,873
Cash and cash equivalents - beginning of the period
3,917,627
3,917,627
3,905,799
-
Cash and cash equivalents - end of the period
3,277,095
3,902,514
3,917,627
-
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

SILO Cash Flow Sankey DiagramSankey diagram visualizing SILO cash flow for the periodsomething is missing$1,315,653 something is missing$2,728,880 Netcash provided byinvesting activities$183,439 (-85.44%↓ Y/Y)Canceled cashflow$1,132,214 Net(decrease) increase in cashand cash...-$625,419 (-246.17%↓ Y/Y)Canceled cashflow$2,912,319 Prepaid expenses andother current assets-$186,016 (-334.91%↓ Y/Y)Amortization of prepaidstock-based professional...$62,500 Stock-based compensation$39,174 (124.56%↑ Y/Y)Unrealized loss on cryptoassets, at fair value-$35,795 Net realized gain onshort-term debt...-$3,054 (-178.09%↓ Y/Y)Amortization expense$2,938 (-47.21%↓ Y/Y)Realized loss on cryptoassets-$2,073 Proceeds from the sale ofshort-term debt...-$1,113,374 (-184.63%↓ Y/Y)Purchases of short-termdebt investments$18,840 (-66.46%↓ Y/Y)Net cash (used in)provided by financing...-$2,755,877 (-231.61%↓ Y/Y)Net cash used inoperating activities-$781,861 (73.27%↑ Y/Y)Canceled cashflow$331,550 something is missing-$2,728,880 Payment of deferredoffering costs$26,997 Net loss-$832,829 (62.75%↑ Y/Y)Accounts payable andaccrued expenses-$178,917 (69.86%↑ Y/Y)Gain on settlement ofaccounts payable and...$91,645 Unrealized gain onshort-term tokenized...$4,961 Staking income on cryptoassets$1,147 Deferred revenue-$1 (100.00%↑ Y/Y)

Silo Pharma, Inc. (SILO)

Silo Pharma, Inc. (SILO)